Abstract
In 2005, this market was valued at $30.6 million and will increase at a
compound annual growth rate of 9.9% over the next five years.
The Europe II interventional neuroradiology transcatheter embolization and
occlusion market consists of Benelux (Belgium, the Netherlands, and
Luxembourg) Spain, Switzerland, and the rest of the Europe (Austria, Denmark,
Finland, Norway, Portugal and Sweden).
|